ADVANCING IMMUNOTHERAPY in ONCOLOGY

Swiss trademark · 582740 · Combined mark · In force

Register entry

Registration number
582740
Application number
62056/2008
Status
In force
Type
Combined mark
As registered
ADVANCING IMMUNOTHERAPY in ONCOLOGY ((fig.))
Filed
Sep 26, 2008
Registered
Feb 9, 2009
Published
Feb 9, 2009
Protected until
Sep 26, 2028
Language of procedure
German
Vienna classes
26.03.23, 26.11.03, 26.11.12
Source
Swissreg

Goods and services

Paper and printed matter

Druckereierzeugnisse in Bezug auf onkologische pharmazeutische Präparate.

Advertising and business services

Verkaufsförderung in Bezug auf onkologische pharmazeutische Präparate.

Education, entertainment and sport

Erziehung und Ausbildung in Bezug auf onkologische pharmazeutische Präparate.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  2. Jan 12, 2018

    Renewed

    Published in Swissreg on 12.01.2018

  3. Feb 9, 2009

    Registered

    Published in Swissreg on 09.02.2009

Parties

Holder

Bristol-Myers Squibb Company

345 Park Avenue, NY 10154 New York, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.